Research Update: Pregnancy and COVID-19 vaccination. This research update was recorded on 10th Sept 2021 on the topic of pregnancy and vaccination against COVID-19. This information is information only and does not take the place of individualised advice and consultation with your medical team. I hope you find this useful, and please feel free to share this resource with anyone you think might be interested. If you’d prefer to read through the information a transcript is available at www.annacusack.com.au/blog. ***
Articles cited:
Brookstein Peretz, S., Regev, N., Novick, L., Nachsol, N., Goffer, E., Ben-David, A. et. al. (2021). Short-term outcome of pregnant women vaccinated with BNT162b2 mRNA Covid-19 vaccine. Ultrasound in Obstetrics & Gynecology, 58(3), 450-456. https://doi.org/10.1002/uog.23729
Gray, K. J., Bordt, E. A., Atyeo, C. A., Deriso, E., Akinwunmi, B., Young, N. et. al. (2021). Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study. American Journal of Obstetrics and Gynecology, 225(3), 303.e1-303.e17. https://doi.org/10.1016/j.ajog.2021.03.023
Knight M, Bunch K, Vousden N, Morris E, Simpson N, Gale C et al. (2020). Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study BMJ 369 :m2107 doi:10.1136/bmj.m2107
Parry, H., Bruton, R., Stephens, C., Brown, K., Amirthalingam, G., Hallis, B., et. al. (2021). Extended interval BNT162b2 vaccination enhances peak antibody generation in older people. Advanced online publication. Doi:10.1101/2021.05.15.21257017
Shimabukuro, T. T., Kim, S. Y., Myers, T. R., Moro, P. L., Oduvebo, T., Panagiotakopoulos, L. et. al. (2021). Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. New England Journal of Medicine, 384, 2273-2282. DOI: 10.1056/NEJMoa2104983
Stebbings, R., Maguire, S., Armour, G., Jones, C., Goodman, J., Maguire, A. K. et al. (2021). Developmental and reproductive safety of AZD1222 (ChAdOx1 nCoV-19) in mice. Reproductive Toxicology, 104, pp.134-142; https://doi.org/10.1016/j.reprotox.2021.07.010
Wei, S. Q., Bilodeau-Bertrand, M., Liu, S. & Auger, N. (2021). The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. CMAJ, 193(16), E540-E548; DOI: https://doi.org/10.1503/cmaj.202604
Zdanowski, W., & Wasniewski, T. (2021). Evaluation of SARS-CoV-2 Spike Protein Antibody Titers in Cord Blood after COVID-19 Vaccination during Pregnancy in Polish Healthcare Workers: Preliminary Results. Vaccines 9(6), 675; https://doi.org/10.3390/vaccines9060675
I also referred to:
-HealthLine. AstraZeneca vs. Pfizer. Published 22nd August, 2021. https://www.healthline.com/health/astrazeneca-vs-pfizer-vaccine
-RANZCOG statement, updated 18th August: https://ranzcog.edu.au/statements-guidelines/covid-19-statement/covid-19-vaccination-information
-WHO statement on Pfizer, last updated 15th June 2021: “Interim recommendations for use of the Pfizer–BioNTech COVID-19 vaccine, BNT162b2, under Emergency Use Listing”. https://apps.who.int/iris/bitstream/handle/10665/341786/WHO-2019-nCoV-vaccines-SAGE-recommendation-BNT162b2-2021.2-eng.pdf?sequence=1
